Huntington National Bank’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $34 | Hold |
1
| – | – | ﹤0.01% | 3163 |
|
|
2025
Q4 | $34 | Hold |
1
| – | – | ﹤0.01% | 3076 |
|
|
2025
Q3 | $34 | Hold |
1
| – | – | ﹤0.01% | 3133 |
|
|
2025
Q2 | $34 | Hold |
1
| – | – | ﹤0.01% | 3161 |
|
|
2025
Q1 | $34 | Hold |
1
| – | – | ﹤0.01% | 3189 |
|
|
2024
Q4 | $34 | Hold |
1
| – | – | ﹤0.01% | 3211 |
|
|
2024
Q3 | $34 | Hold |
1
| – | – | ﹤0.01% | 3198 |
|
|
2024
Q2 | $34 | Hold |
1
| – | – | ﹤0.01% | 3159 |
|
|
2024
Q1 | $34 | Hold |
1
| – | – | ﹤0.01% | 3016 |
|
|
2023
Q4 | $34 | Hold |
1
| – | – | ﹤0.01% | 2915 |
|
|
2023
Q3 | $34 | Hold |
1
| – | – | ﹤0.01% | 2892 |
|
|
2023
Q2 | $34 | Hold |
1
| – | – | ﹤0.01% | 2866 |
|
|
2023
Q1 | $34 | Hold |
1
| – | – | ﹤0.01% | 2709 |
|
|
2022
Q4 | $33 | Hold |
1
| – | – | ﹤0.01% | 2594 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2516 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2523 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2461 |
|
|
2021
Q4 | $0 | Sell |
1
-57
| -98% | -$1.09K | ﹤0.01% | 2391 |
|
|
2021
Q3 | $1K | Buy |
+58
| New | +$1.16K | ﹤0.01% | 1762 |
|
|
2016
Q2 | – | Sell |
-220
| Closed | -$4K | – | 1716 |
|
|
2016
Q1 | $4K | Hold |
220
| – | – | ﹤0.01% | 1604 |
|
|
2015
Q4 | $5K | Hold |
220
| – | – | ﹤0.01% | 1476 |
|
|
2015
Q3 | $4K | Hold |
220
| – | – | ﹤0.01% | 1567 |
|
|
2015
Q2 | $4K | Hold |
220
| – | – | ﹤0.01% | 1637 |
|
|
2015
Q1 | $4K | Sell |
220
-2,762
| -93% | -$51.1K | ﹤0.01% | 1613 |
|
|
2014
Q4 | $49K | Buy |
+2,982
| New | +$51.2K | ﹤0.01% | 1129 |
|
|
2014
Q2 | – | Sell |
-103,246
| Closed | -$2.25M | – | 1112 |
|
|
2014
Q1 | $2.25M | Buy |
103,246
+97,500
| +1,697% | +$2.23M | 0.04% | 404 |
|
|
2013
Q4 | $152K | Sell |
5,746
-224
| -4% | -$5.51K | ﹤0.01% | 780 |
|
|
2013
Q3 | $141K | Buy |
5,970
+200
| +3% | +$4.67K | ﹤0.01% | 770 |
|
|
2013
Q2 | $124K | Buy |
+5,770
| New | +$124K | ﹤0.01% | 785 |
|
Huntington National Bank's VIVO Position: Q1 2026 in Review
Huntington National Bank held its Meridian Bioscience Inc (VIVO) position steady in Q1 2026 at 1 share worth $34. The position accounts for ﹤0.01% of the portfolio, ranked #3163.
Huntington National Bank first reported a position in VIVO in Q2 2013 and has held it in 29 quarters since. The position peaked at $2.25M in Q1 2014. 1 fund tracked by Wall St. Rank holds VIVO as of Q1 2026.
- Huntington National Bank held 1 share of Meridian Bioscience Inc worth $34 as of Q1 2026.
- Huntington National Bank left its Meridian Bioscience Inc share count unchanged in Q1 2026.
- Meridian Bioscience Inc made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #3163 holding.
- Huntington National Bank first reported a position in Meridian Bioscience Inc in Q2 2013 and has held it in 29 quarters since.
- Huntington National Bank's Meridian Bioscience Inc position peaked at $2.25M in Q1 2014.
- 1 fund tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.